Keystone Financial Group

Position in GILD — Gilead Sciences, Inc.

CIK 1729299 LEXINGTON, KY

Position in GILD

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$523,300

-$15,086 QoQ

Shares Held

4,142

+7.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#1,350

of 2,266 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Keystone Financial Group holds $28,513,517 across 12 Drug Manufacturers - General names. GILD ranks #7 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	47,287	$12,009,479
2	LLY	ELI LILLY & Co	4,531	$5,434,617
3	ABBV	AbbVie Inc.	14,346	$3,610,027
4	MRK	Merck & Co., Inc.	19,960	$2,564,860
5	PFE	Pfizer Inc	80,610	$1,941,088
6	AMGN	Amgen Inc	2,034	$736,552
7	GILD	Gilead Sciences, Inc. This page	4,142	$523,300
8	BMY	Bristol Myers Squibb Co	8,578	$494,264

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$523,300	4,142	+7.2%	Shares	Sole	2026-07-29
2026-03-31	$538,386	3,863	-11.8%	Shares	Sole	2026-05-13
2025-12-31	$537,846	4,382	-1.1%	Shares	Sole	2026-02-06
2025-09-30	$491,952	4,432	+28.8%	Shares	Sole	2025-11-17
2025-06-30	$381,614	3,442	+30.9%	Shares	Sole	2025-08-13
2025-03-31	$294,579	2,629	-17.4%	Shares	Sole	2025-05-13
2021-12-31	$231,045	3,182	-18.0%	Shares	Sole	2022-02-11
2021-09-30	$271,157	3,882	-7.2%	Shares	Sole	2021-11-12
2021-06-30	$287,972	4,182	0.0%	Shares	Sole	2021-08-13
2021-03-31	$270,282	4,182	-0.8%	Shares	Sole	2021-05-11
2020-12-31	$245,682	4,217	+3.9%	Shares	Sole	2021-02-10
2020-09-30	$256,361	4,057	-12.8%	Shares	Sole	2020-11-13
2020-06-30	$357,847	4,651	-20.1%	Shares	Sole	2020-08-13
2020-03-31	$435,028	5,819	—	Shares	Sole	2020-05-05
No filing history on record for this holder in this stock.